HSF1 and cancer: Since inhibition of HSF1 appears to be a promising therapeutic strategy for cancer treatment, the first attempts to develop a targeted inhibitor of HSF1 activity were made using natural compounds with pleiotropic activity (e.g., quercetin or triptolide) [44].